Table 4.

Effect of clinicopathologic parameters on the mean of survival rate in patients with glioblastoma

P-value (log-rank)	Mean and SD of survival (months)	Clinicopathologic parameters
0.005	10.7±1.2	40<=		Age
	18.1±1.74	40>
0.512	12.7±1.64	Frontal		Tumor location
	13.6±1.92	Temporal
	14.8±3.24	Parietal
	18.2±3	Occipital
	10.14±2	Other sites
0.30	12.3±1.4	Male		Gender
	14.6±1.5	Female
0.018	18.9±1.77	80<=		Kps score
	11.6±1.15	80>
0.325	18.00±2.5	-	SOX-6 expression
	12.63±2.2	1+
	12.29±1.8	2+
	11.7±1.7	3+
0.021	17.7±2.17	-	GAGE expression
	13.7±2.17	1+
	11.28±2.7	2+
	7.6±1.20	3+
0.001	18.1±2.15	-	MAGE-E1 expression
	21.2±1.4	1+
	15±2.4	2+
	9.4±1.09	3+
0.001	18.1±2.15	-	MAGE-E1 intensity
	19±2.3	Weak (1+)
	14±1.9	Intermediate (2+)
	8.6±1.14	Strong (3+)
0.037	18.6±1.7	˃2	MAGE-E1 final score
	10±0	2-3
	11.4±1.1	4-6